{"filing":{"accession_number":"0001477449-26-000040","cik":"0001477449","ticker":"TDOC","company_name":"Teladoc Health, Inc.","form":"8-K","filing_date":"2026-08-03","report_date":"2026-08-03","primary_document":"tdoc-20260803.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744926000040/tdoc-20260803.htm"},"events":[{"id":23166,"run_id":20963,"accession_number":"0001477449-26-000040","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Mark V. Anquillare was appointed as a director of Teladoc Health, effective August 3, 2026, and concurrently appointed to the audit and compensation committees. The Board determined he qualifies as an independent director and audit committee financial expert.","company_name":"Teladoc Health, Inc.","ticker":"TDOC","filing_date":"2026-08-03","form":"8-K","submitted_at":null,"items":[{"id":23324,"accession_number":"0001477449-26-000040","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mark V. Anquillare as a director of Teladoc Health, effective August 3, 2026, with concurrent appointments to the audit and compensation committees. The Board determined he qualifies as an independent director and audit committee financial expert. This is a material governance event affecting board composition and committee oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:38:32.121872+00:00","company_name":"","ticker":null,"filing_date":""},{"id":23325,"accession_number":"0001477449-26-000040","item_number":"7.01","item_title":"Regulation FD.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mark V. Anquillare to Teladoc Health's board of directors, effective August 3, 2026. Although Item 7.01 (Regulation FD) is used to furnish the press release, the substantive event is a board appointment, which is a governance matter typically disclosed under Item 5.02. The appointment of a financial executive with 30+ years of experience and prior CFO/COO roles at a public company to the board, including service on Audit \u0026 Compensation committees, is material to investors' assessment of board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:38:32.121872+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23324,"accession_number":"0001477449-26-000040","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mark V. Anquillare as a director of Teladoc Health, effective August 3, 2026, with concurrent appointments to the audit and compensation committees. The Board determined he qualifies as an independent director and audit committee financial expert. This is a material governance event affecting board composition and committee oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:38:32.121872+00:00","company_name":"Teladoc Health, Inc.","ticker":"TDOC","filing_date":"2026-08-03"},{"id":23325,"accession_number":"0001477449-26-000040","item_number":"7.01","item_title":"Regulation FD.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mark V. Anquillare to Teladoc Health's board of directors, effective August 3, 2026. Although Item 7.01 (Regulation FD) is used to furnish the press release, the substantive event is a board appointment, which is a governance matter typically disclosed under Item 5.02. The appointment of a financial executive with 30+ years of experience and prior CFO/COO roles at a public company to the board, including service on Audit \u0026 Compensation committees, is material to investors' assessment of board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:38:32.121872+00:00","company_name":"Teladoc Health, Inc.","ticker":"TDOC","filing_date":"2026-08-03"}]}